Giant Biogene (02367) spent 13.9713 million Hong Kong dollars to repurchase 400,000 shares on December 17th.
Jinzi Biotech (02367) announced that on December 17, 2025, the company spent HKD 13.9713 million to repurchase 400,000 shares at a price of HKD 34.62-35.22 per share.
GIANT BIOGENE (02367) announced on December 17, 2025 that the company will spend HK $13,971,300 to repurchase 400,000 shares, at a repurchase price range of HK $34.62-35.22 per share.
Related Articles
C-MER MEDICAL (03309) sells 55% equity stake in Apollo to Mingda Glasses.
SICC Co., Ltd. (02631) received a total reduction of 3.0316 million shares of the company's stock from Hubble Investments.
LEVER STYLE (01346) plans to acquire AAG Australia and America assets for $13 million.
C-MER MEDICAL (03309) sells 55% equity stake in Apollo to Mingda Glasses.
SICC Co., Ltd. (02631) received a total reduction of 3.0316 million shares of the company's stock from Hubble Investments.
LEVER STYLE (01346) plans to acquire AAG Australia and America assets for $13 million.
RECOMMEND
Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
16/12/2025
What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
16/12/2025
Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
16/12/2025
